1-aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance

Life Sciences

Volumn 55, Issue 18, 1994, Pages 1393-1398

  Kolesnikov, Yuri A ^a   Maccechini, Maria Luisa ^c   Pasternak, Gavril W ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c Symphony Pharmaceuticals   (United States)

Author keywords

488H; enkephalin; glycine; morphine; naloxone benzoylhydrazone; NMDA receptor; opiate; U50

Indexed keywords

1 AMINOCYCLOPROPANECARBOXYLIC ACID; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE;

ANALGESIA; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG THERAPY; DRUG TOLERANCE; INTRATHECAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PREVENTION; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINO ACIDS; ANALGESIA; ANIMAL; DRUG TOLERANCE; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; MALE; MICE; MORPHINE; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

ANIMALIA;

EID: 0027980235     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(94)00753-5     Document Type: Article

References (30)